Xocova has been approved in Japan since 2022 for treating COVID-19, and was approved in March in Japan for prophylactic use. The FDA is currently reviewing Xocova, with an initial decision set for June 16. Sign my petition to the FDA urging approval -> www.change.org/p/urge-the-f...
www.change.org
Urge the FDA to approve the Xocova antiviral for COVID-19